References and Notes
-
1a
Evans BE.
Rittle KE.
Bock MG.
DiPardo RM.
Freidinger RM.
Whitter WL.
Lundell GF.
Veber
DF.
Anderson PS.
Chang RSL.
Lotti VJ.
Cerino DJ.
Chen TB.
Kling PJ.
Kunkel KA.
Springer JP.
Hirshfield J.
J. Med. Chem.
1988,
31:
2235
-
1b
Horton DA.
Bourne GT.
Smythe ML.
Chem. Rev.
2003,
103:
893
-
1c
Kumar A.
Maurya RA.
Ahmad P.
J.
Comb. Chem.
2009,
11:
198
- 2
Kale RR.
Prasad V.
Mohapatra P.
Tiwari VK.
Monatsh. Chemie
2010,
141:
1159
- 3
Lawrence RN.
Drug
Discovery Today
2000,
5:
172
- 4
Molnar A.
Boros S.
Simon K.
Hermecz I.
Gonczi C.
ARKIVOC
2010,
(x):
199
-
5a
Kim TH.
Lee N.
Lee G.
Kim JN.
Tetrahedron
2001,
57:
7137
-
5b
Gama Y.
Shibuya I.
Shimizu M.
Chem.
Pharm. Bull.
2002,
50:
1517
-
5c
Gama Y.
Shibuya I.
Shimizu M.
Goto M.
J. Carbohydr. Chem.
2001,
20:
459
-
5d
Alhede B.
Clamen FP.
Christensen J.
McCluskey KK.
Preikschat HF.
J. Org. Chem.
1991,
56:
2139
-
5e
Chern J.
Groziak MP.
Townsend LB.
J. Heterocycl. Chem.
1986,
23:
153
- 6
Mhaske SB.
Argade NP.
Tetrahedron
2006,
62:
9787
-
7a
Tiwari VK.
Singh DD.
Hussain HA.
Mishra BB.
Singh A.
Monatsh.
Chemie
2008,
139:
43
-
7b
Tiwari VK.
Hussain HA.
Mishra BB.
Singh DD.
Tripathi V.
Med. Chem. Res.
2007,
15:
325
-
7c
Tiwari VK.
Kale RR.
Mishra BB.
Singh A.
ARKIVOC
2008,
(xiv):
27
-
8a
Kale RR.
Prasad V.
Tiwari VK.
Tetrahedron Lett.
2010,
51:
5740
-
8b
Kale RR.
Prasad V.
Tiwari VK.
Lett. Org. Chem.
2010,
7:
136
-
8c
Tiwari VK.
Singh A.
Hussain HA.
Mishra BB.
Tripathi V.
Monatsh. Chem.
2007,
138:
1297
-
8d
Singh A.
Kale RR.
Tiwari VK.
Trends
Carbohydr. Res.
2009,
1:
80
-
9a
Pandey J.
Sharma A.
Tiwari VK.
Dube D.
Ramachandran R.
Chaturvedi V.
Sinha S.
Mishra NN.
Shulka PK.
Tripathi RP.
J. Comb. Chem.
2009,
11:
422
-
9b
Yu H.
Cheng J.
Ding L.
Khedri Z.
Chen Y.
Lau K.
Tiwari VK.
Chen Xi.
J.
Am. Chem. Soc.
2009,
131:
18467
-
9c
Tewari N.
Katiyar D.
Tiwari VK.
Tripathi RP.
Tetrahedron Lett.
2002,
44:
6639
-
9d
Tewari N.
Mishra RC.
Tiwari VK.
Tripathi RP.
Synlett
2002,
1779
-
9e
Tewari N.
Tiwari VK.
Mishra RC.
Tripathi RP.
Srivastava AK.
Ahmad R.
Srivastava R.
Srivastava BS.
Bioorg.
Med. Chem.
2003,
11:
2911
-
9f
Saxena N.
Verma SS.
Tiwari VK.
Chaturvedi V.
Manju YK.
Srivastva AK.
Gaikwad A.
Sinha S.
Tripathi RP.
Bioorg. Med. Chem.
Lett.
2006,
14:
8186
10
Typical Experimental
Procedure for the Synthesis of Quinazolinone-Fused Azauracil Compounds
3a-h
Diverse 2-thioxo-2,3-dihydroquinazolin-4
(1H)-ones 2a-h were obtained in good yield by the one-pot
reaction of anthranilic acid/esters, primary amines, and
bis(benzo-triazol-1-yl)methanethione in presence of the amidine
base as per ref. 7. Thioquinazolinone (2a,
0.5 g 1.96 mmol) was added in anhyd MeCN (8 mL) and stirred for
10 min then AgCNO (0.59 g, 3.93 mmol) was added in above solution. Solid
precipitated out within 5 min and reaction mixture was further stirred
for 30 min, where reaction mass turns into greenish color. Progress
of reaction was monitored by TLC (25% EtOAc in n-hexane). After completion of reaction, product
was filtered, dried, and subjected to column chromatography (25% EtOAc
in n-hexane) to obtain pure white solid
(90-95% yield).
Compound 3a:
yield 91%; mp 160-162 ˚C. IR
(KBr): νmax = 3429 (NH), 1676, 1591,
1568, 1508 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 8.04
(d, J = 7.5
Hz, 1 H), 7.83 (t, J = 7.2 Hz,
1 H), 7.71 (d, J = 8.4
Hz, 1 H), 7.43 (m, 4 H), 6.77 (m, 2 H). ¹³C
NMR (75 MHz, CDCl3): δ = 166.10,
161.03, 145.95, 139.88, 134.52, 129.39, 129.16, 128.14, 128.04, 126.49,
124.01, 119.64 ppm. Anal. Calcd for C16H10N4O3:
C, 62.74; H, 3.29; N, 18.29. Found: C, 62.51; H, 3.75; N, 18.88.
Compound 3b: yield 91%; mp 178-180 ˚C.
IR (KBr): νmax = 3431 (NH), 1669, 1596,
1569, 1511 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 11.02
(br s, 1 H, NH), 7.96 (d, J = 7.8
Hz, 2 H), 7.67 (t, J = 8.4
Hz, 2 H), 7.48 (d, J = 8.4
Hz, 1 H), 7.34 (t, J = 8.4
Hz, 1 H), 7.04 (t, J = 8.7
Hz, 2 H), 6.69 (s, 1 H). ¹³C NMR (75
MHz, CDCl3): δ = 167.84,
162.0, 140.91, 134.79, 134.79, 133.17, 133.06, 130.66, 129.96, 126.84, 123.90,
123.41, 118.27 ppm. Anal. Calcd for C19H11N5O3S: C,
58.61; H, 2.85; N, 17.99. Found: C, 58.22; H, 3.01; N, 18.45.
Compound 3c: yield 91%; mp 187-188 ˚C.
IR (KBr): νmax = 3430, 1677, 1593,
1577, 1507 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 9.82
(br s, NH, 1 H), 8.42 (d, J = 9.0
Hz, 2 H), 8.23 (m, 2 H), 7.77 (t, J = 7.8
Hz, 1 H), 7.48 (d, J = 8.7
Hz, 1 H), 7.38 (m, 1 H), 7.15 (d, J = 8.7
Hz, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 165.5,
159.90, 145.33, 143.27, 137.98, 133.80, 129.00, 125.60, 124.35,
122.55, 122.42, 114.37, 114.17, 110.53 ppm.
Compound 3d: yield 91%; mp 171-173 ˚C.
IR (KBr): νmax = 3433 (NH), 1677 (O=CN),
1622, 1529 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 8.35
(d, J = 8.7
Hz, 2 H), 7.99-7.89 (m, merged with J = 7.2
Hz, 2 H), 7.75 (d, J = 8.4
Hz, 1 H), 7.49 (d, J = 8.1
Hz, 2 H), 7.33 (t, J = 7.5
Hz, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 165.10,
159.07, 145.90, 139.54, 135.41, 130.72, 130.27, 130.17, 127.27,
126.27, 126.10, 124.39, 124.34 ppm. Anal. Calcd for C16H9FN4O3:
C, 59.26; H, 2.80; N, 17.28. Found: C, 59.93; H, 2.74; N, 17.97.